Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - Asset Resilience Ratio

Latest as of September 2024: 0.02%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has an Asset Resilience Ratio of 0.02% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Guangzhou Baiyunshan Pharmaceutical Hold (GU5) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€14.00 Million
≈ $16.37 Million USD Cash + Short-term Investments

Total Assets

€79.26 Billion
≈ $92.66 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Asset Resilience Ratio has changed over time. See GU5 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou Baiyunshan Pharmaceutical Hold stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €14.00 Million 0.02%
Total Liquid Assets €14.00 Million 0.02%

Asset Resilience Insights

  • Limited Liquidity: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited maintains only 0.02% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Industry Peers by Asset Resilience Ratio

Compare Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
Medical Distribution 1.77%
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%

Annual Asset Resilience Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.01% €4.00 Million
≈ $4.68 Million
€78.59 Billion
≈ $91.88 Billion
-0.07pp
2022-12-31 0.08% €56.87 Million
≈ $66.49 Million
€74.67 Billion
≈ $87.29 Billion
+0.07pp
2020-12-31 0.01% €4.00 Million
≈ $4.68 Million
€59.76 Billion
≈ $69.87 Billion
-2.99pp
2018-12-31 3.00% €1.54 Billion
≈ $1.80 Billion
€51.48 Billion
≈ $60.19 Billion
+2.98pp
2017-12-31 0.02% €4.88 Million
≈ $5.70 Million
€28.31 Billion
≈ $33.10 Billion
-0.01pp
2016-12-31 0.02% €6.03 Million
≈ $7.05 Million
€25.90 Billion
≈ $30.28 Billion
-0.25pp
2015-12-31 0.27% €43.19 Million
≈ $50.49 Million
€15.87 Billion
≈ $18.55 Billion
--
pp = percentage points

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution
Market Cap
$457.61 Million
€391.42 Million EUR
Market Cap Rank
#12996 Global
#1353 in Germany
Share Price
€1.78
Change (1 day)
-0.56%
52-Week Range
€1.76 - €2.30
All Time High
€2.30
About

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, … Read more